Company: HSDTW
Filing Date: 2025-01-31
Form Type: S-3
Source: 0001104659-25-008126
Chunk: 3

Company: Solana Co
Filing Date: 2025-01-31
Form: S-3
Chunk 3
---
 ​ | ​ |
| ​ | SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS | ​ | ​ | ​ | ​ |  2 | ​ | ​ |
| ​ | THE OFFERING                                      | ​ | ​ | ​ | ​ |  5 | ​ | ​ |
| ​ | RISK FACTORS                                      | ​ | ​ | ​ | ​ |  6 | ​ | ​ |
| ​ | USE OF PROCEEDS                                   | ​ | ​ | ​ | ​ |  7 | ​ | ​ |
| ​ | SELLING STOCKHOLDERS                              | ​ | ​ | ​ | ​ |  8 | ​ | ​ |
| ​ | DESCRIPTION OF CAPITAL STOCK                      | ​ | ​ | ​ | ​ | 10 | ​ | ​ |
| ​ | PLAN OF DISTRIBUTION                              | ​ | ​ | ​ | ​ | 14 | ​ | ​ |
| ​ | LEGAL MATTERS                                     | ​ | ​ | ​ | ​ | 16 | ​ | ​ |
| ​ | EXPERTS                                           | ​ | ​ | ​ | ​ | 16 | ​ | ​ |
| ​ | WHERE YOU CAN FIND MORE INFORMATION               | ​ | ​ | ​ | ​ | 17 | ​ | ​ |
| ​ | INCORPORATION BY REFERENCE                        | ​ | ​ | ​ | ​ | 18 | ​ | ​ |

i

TABLE OF CONTENTS

### ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement filed with the U.S. Securities and Exchange Commission, or the SEC, using a “shelf” registration process. By using a shelf registration statement, the selling stockholders may sell up to 6,213,888 shares of our common stock from time to time in one or more offerings as described in this prospectus. We will not receive any proceeds from the sale by the selling stockholders of the Securities offered pursuant to this prospectus.

We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part that may contain material information relating to these offerings. The prospectus supplement or post-effective amendment may also add, update or change information contained in this prospectus with respect to that offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. Before purchasing any securities, you should carefully read this prospectus, any